BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gklavas A, Dellaportas D, Papaconstantinou I. Risk factors for postoperative recurrence of Crohn's disease with emphasis on surgical predictors. Ann Gastroenterol. 2017;30:598-612. [PMID: 29118554 DOI: 10.20524/aog.2017.0195] [Cited by in Crossref: 6] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Yoo JH, Holubar S, Rieder F. Fibrostenotic strictures in Crohn's disease. Intest Res 2020;18:379-401. [PMID: 32259917 DOI: 10.5217/ir.2019.09148] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
2 Iheozor-Ejiofor Z, Gordon M, Clegg A, Freeman SC, Gjuladin-Hellon T, MacDonald JK, Akobeng AK. Interventions for maintenance of surgically induced remission in Crohn's disease: a network meta-analysis. Cochrane Database Syst Rev 2019;9:CD013210. [PMID: 31513295 DOI: 10.1002/14651858.CD013210.pub2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
3 Masaki T, Kishiki T, Kojima K, Asou N, Beniya A, Matsuoka H. Recent trends (2016-2017) in the treatment of inflammatory bowel disease. Ann Gastroenterol Surg 2018;2:282-8. [PMID: 30003191 DOI: 10.1002/ags3.12177] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
4 Bislenghi G, Fieuws S, Wolthuis A, Vanbeckevoort D, Ferrante M, Sabino J, Vermeire S, D'Hoore A. Positioning strictureplasty in the treatment of extensive Crohn's disease ileitis: a comparative study with ileocecal resection. Int J Colorectal Dis 2021;36:791-9. [PMID: 33479821 DOI: 10.1007/s00384-021-03837-6] [Reference Citation Analysis]
5 Stavely R, Abalo R, Nurgali K. Targeting Enteric Neurons and Plexitis for the Management of Inflammatory Bowel Disease. Curr Drug Targets 2020;21:1428-39. [PMID: 32416686 DOI: 10.2174/1389450121666200516173242] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
6 Gjuladin-Hellon T, Gordon M, Iheozor-Ejiofor Z, Akobeng AK. Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease. Cochrane Database Syst Rev 2019;6:CD008414. [PMID: 31220875 DOI: 10.1002/14651858.CD008414.pub3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Gklavas A, Tiniakos D, Karandrea D, Karamanolis G, Bamias G, Papaconstantinou I; Hellenic Group for the Study of IBD. Specific Neuropeptide Expression in Crohn's Disease Ileocolonic Resection Specimens Is Not Associated with Plexitis at the Ileal Margin or Postoperative Recurrence. J Gastrointest Surg 2022. [PMID: 34997467 DOI: 10.1007/s11605-021-05215-7] [Reference Citation Analysis]
8 Georgopoulos I, Mavrigiannaki E, Stasinopoulou S, Renieris G, Nikolakis G, Bamias G, Tiniakos D, Papaconstantinou I. Experimental Intestinal Stenosis Alters Crohn's Disease-Like Intestinal Inflammation in Ileitis-Prone Mice. Dig Dis Sci 2021. [PMID: 34350516 DOI: 10.1007/s10620-021-07161-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Wu E, Duan M, Han J, Zhang H, Zhou Y, Cao L, Gong J, Guo Z, Li Y, Zhu W. Patients with Crohn's Disease Undergoing Abdominal Surgery: Clinical and Prognostic Evaluation Based on a Single-Center Cohort in China. World J Surg 2021. [PMID: 34718840 DOI: 10.1007/s00268-021-06366-z] [Reference Citation Analysis]
10 Tang S, Liu W, Qi W, Yu T, Cao Q, Ge X, Zhou W. Real-World Experience with AGA Guidelines in the Management of Crohn's Disease following Ileocolonic Resection: A Retrospective Cohort Study. Gastroenterol Res Pract 2020;2020:8618574. [PMID: 32382273 DOI: 10.1155/2020/8618574] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Kim JY, Park SH, Park JC, Noh S, Lee JS, Kim J, Ham NS, Oh EH, Hwang SW, Yang DH, Ye BD, Byeon JS, Myung SJ, Lee JL, Yoon YS, Yu CS, Yang SK. The Clinical Significance of Anastomotic Ulcers After Ileocolic Resection to Predict Postoperative Recurrence of Crohn's Disease. Dig Dis Sci 2021;66:3132-40. [PMID: 32926261 DOI: 10.1007/s10620-020-06599-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Turri G, Carvello M, Ben David N, Spinelli A. Intriguing Role of the Mesentery in Ileocolic Crohn's Disease. Clin Colon Rectal Surg. [DOI: 10.1055/s-0042-1743590] [Reference Citation Analysis]
13 Zhou J, Li Y, Gong J, Zhu W. Frequency and risk factors of surgical recurrence of Crohn's disease after primary bowel resection. Turk J Gastroenterol. 2018;29:655-663. [PMID: 30381273 DOI: 10.5152/tjg.2018.17774] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Kim SB, Cheon JH, Park JJ, Kim ES, Jeon SW, Jung SA, Park DI, Lee CK, Im JP, Kim YS, Kim HS, Lee J, Eun CS, Lee JM, Jang BI, Seo GS. Risk Factors for Postoperative Recurrence in Korean Patients with Crohn's Disease. Gut Liver 2020;14:331-7. [PMID: 31550869 DOI: 10.5009/gnl19085] [Reference Citation Analysis]
15 Chande N, Singh S, Narula N, Gordon M, Kuenzig ME, Nguyen TM, MacDonald JK, Feagan BG. Medical Management Following Surgical Therapy in Inflammatory Bowel Disease: Evidence from Cochrane Reviews. Inflamm Bowel Dis 2021:izaa350. [PMID: 33452527 DOI: 10.1093/ibd/izaa350] [Reference Citation Analysis]
16 Chen ZX, Chen YL, Huang XM, Lin XT, He XW, Lan P. Risk factors for recurrence after bowel resection for Crohn’s disease. World J Gastrointest Pharmacol Ther 2019; 10(4): 67-74 [PMID: 31692953 DOI: 10.4292/wjgpt.v10.i4.67] [Cited by in CrossRef: 2] [Article Influence: 0.7] [Reference Citation Analysis]